Physicians Living the Proof
What Physicians Are Saying About Intracept
Robert Ball, MD
Southwest Florida Pain Center, Venice, FL
“The Intracept procedure has revolutionized the treatment of back pain in my practice. I am proud to be one of the first physicians performing this procedure in my region.”
Douglas P. Beall, MD
Clinical Radiology of Oklahoma, Edmond, OK
“I’ve found that the Intracept Procedure has become an indispensable treatment for patients with stable discogenic back pain associated with degenerative disc disease and degenerative endplate changes. It can produce prominent pain relief and improvement in function through incisions even too small to close with a suture or a staple.”
Brian Durkin, DO
Pain Institute of Long Island, NY
“If I see people with Modic changes I say, ‘that’s probably where your back pain is coming from. It’s probably your vertebrogenic endplate changes that are causing your back pain.’ So that’s been a big change in our algorithm. We’ll see patients for the first time and see if we can get them in the portal and treated.”
Erik Ekstrom, MD
Summit Orthopedics, Plymouth, MN
“In the many years of caring for spine conditions, I have found the Intracept treatment to have the greatest life changing impact on chronic low back pain.”
Robert Funk, MD
Indiana Spine Group, Carmel, IN
“With this minimally invasive, outpatient procedure, patients may experience significant relief of their vertebrogenic low back pain without traditional spine surgery. This is a true game changer.”
Anthony Giuffrida, MD
Cantor Spine Center at the Paley Orthopedic & Spine Institute
Fort Lauderdale, FL
“For my patients with chronic low back pain who do not respond to conservative treatment therapies, the Intracept Procedure is a great option. We are now able to treat a part of the spine that we have not treated in the past. This outpatient, minimally invasive procedure targets the pain-sensing basivertebral nerve. By blocking these pain signals, we may alleviate their chronic pain for good.”
Brad Goodman, MD
OrthoAlabama, Birmingham, AL
“The Intracept procedure has been a game changer in my practice for patients with chronic low back pain.”
Sven Hochheimer, MD
Wyoming Spine & Neurosurgery, Cheyenne, WY
“A fantastic minimally invasive option for patients with chronic low back pain.”
Jad G. Khalil, MD
Michigan Orthopaedic Surgeons, PLLC, Southfield, MI
“The understanding of vertebrogenic back pain and the implications of Modic changes have changed the way we approach this subset of patients. As a surgeon, I would ordinarily turn those patients down for surgery. The Intracept Procedure provides a unique solution for this type of pathology. Doctors adopting Intracept have figured out where to put Intracept in their care pathway.”
Paul Lin, MD
OSS Health, York, PA
“This has been one of the most powerful interventions that has developed in my career. Patients are often getting relief for a condition that previously only had surgery as an option.”
Ramana Naidu, MD
California Orthopedics & Spine, Larkspur, CA
“Intracept is addressing an unmet need in chronic low back pain that interventional pain and spine surgery has been challenged by for years.”
Kiran V. Patel, MD
Director, Neurosurgical Pain, Lenox Hill Hospital
“For the right patient with lower back pain, the Intracept procedure is life changing. Of all of the procedures that I perform, it has delivered the most dramatic results for my patients.”
Tyler Ptacek, MD
Rapid City Medical Center Interventional Pain
Rapid City, SD
“The Intracept procedure has improved so many of my patients’ quality of life.”
David Tran, MD
Axion Spine & Neurosurgery, Alpharetta, GA
“Intracept is an innovative, safe, and highly effective treatment for chronic low back pain. Patients may see dramatic, lasting improvements from this minimally invasive procedure, with limited post-procedure pain and a quick recovery time.”
Proven Relief of Vertebrogenic Pain
NEARLY 80%
of patients in a recent long-term study would have the Intracept Procedure again for the same condition.
LESS THAN 0.3%
AFTER 5 YEARS, 65% OF
patients reported they had resumed the level of activity they enjoyed prior to low back pain in a recent long-term study.
BASED ON OVER 30 YEARS
of research.
As with any surgical procedure, there are risks and considerations associated with the Intracept Procedure. See important safety information below.
Patients: See the Indications & Risks Involved
The Intracept® Procedure is indicated for patients who have had chronic low back pain for at least six months, who have tried conservative care for at least six months, and whose MRI shows features consistent with Modic changes – indicating damage at the vertebral endplates has led to inflammation.
Not every patient who meets these criteria is a candidate for the Intracept Procedure, however – in fact, there are specific characteristics indicating a patient should not be considered for the procedure. These contraindications include being pregnant, having weakened cardiac or pulmonary function, having an implanted electronic medical device in the body (such as a pacemaker or defibrillator), being diagnosed with a systemic or local infection, or having an anatomy that could be damaged unintentionally while ablating the basivertebral nerve (based on your physicians’ clinical review). The Intracept Procedure is also contraindicated in patients who are skeletally immature – which generally means individuals under the age of 18 are not candidates. There are also certain risks and precautions regarding the procedure which you should be aware of before proceeding.
Talk with your doctor about what indicates, and contraindicates, certain patients for the Intracept Procedure – as well as the risks and precautions for the procedure.
Physicians: See Indications, Contraindications, and Risks
The Intracept Procedure Intraosseous Nerve Ablation System is intended to be used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for the relief of chronic low back pain of at least six months duration that has not responded to at least six months of conservative care, and is also accompanied by features consistent with Type 1 or Type 2 Modic changes on an MRI such as inflammation, edema, vertebral endplate changes, disruption and fissuring of the endplate, vascularized fibrous tissues within the adjacent marrow, hypointensive signals (Type 1 Modic change), and changes to the vertebral body marrow including replacement of normal bone marrow by fat, and hyperintensive signals (Type 2 Modic change).
Use of the Intracept Procedure Intraosseous Nerve Ablation System is contraindicated in:
- Patients with severe cardiac or pulmonary compromise
- Patients where the targeted ablation zone is < 10 mm away from a sensitive structure not intended to be ablated, including the vertebral foramen (spinal canal)
- Patients with active systemic infection or local infection in the area to be treated
- Patients who are pregnant
- Skeletally immature patients (generally < 18 years of age)
- Patients with active implantable pulse generators (e.g., pacemakers, defibrillators)
- Situations where unintended tissue damage may result, based on the clinical assessment by the physician
- Application with electrosurgical instruments NOT tested and specified for use with the Relievant RFG
As with any surgical procedure, there are risks and considerations associated with the Intracept Procedure. To review the contraindications, warnings, and precautions click here.